ProfileGDS4718 / 231040_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 3% 6% 14% 8% 13% 15% 13% 10% 5% 9% 11% 11% 10% 8% 7% 10% 15% 18% 16% 13% 11% 20% 20% 9% 12% 11% 12% 5% 9% 6% 8% 12% 9% 8% 9% 9% 12% 10% 5% 43% 7% 8% 21% 3% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.484093
GSM549102patient 115, normal, homogenized [OPG study]3.635616
GSM549104patient 119, normal, homogenized [OPG study]3.8914
GSM549108patient 138, normal, homogenized [OPG study]3.738598
GSM549119patient 077, normal, homogenized [OPG study]3.8991313
GSM549133patient 032, cancer, homogenized [OPG study]3.9029915
GSM549139patient 042, cancer, homogenized [OPG study]3.8628513
GSM549099patient 107, normal, homogenized [OPG study]3.7800910
GSM549109patient 139, normal, homogenized [OPG study]3.595115
GSM549110patient 046, normal, homogenized [OPG study]3.747649
GSM549114patient 063, normal, homogenized [OPG study]3.7866711
GSM549122patient 082, normal, homogenized [OPG study]3.8267511
GSM549134patient 033, cancer, homogenized [OPG study]3.7863410
GSM549136patient 036, cancer, homogenized [OPG study]3.644998
GSM549140patient 044, cancer, homogenized [OPG study]3.64147
GSM549111patient 047, normal, homogenized [OPG study]3.7487610
GSM549113patient 057, normal, homogenized [OPG study]3.9158915
GSM549132patient 031, cancer, homogenized [OPG study]4.0669818
GSM549137patient 038, cancer, homogenized [OPG study]3.9754416
GSM549142patient 047, cancer, homogenized [OPG study]3.9521913
GSM549100patient 110, normal, homogenized [OPG study]3.8004111
GSM549107patient 135, normal, homogenized [OPG study]4.1121720
GSM549115patient 068, normal, homogenized [OPG study]4.0815720
GSM549116patient 072, normal, homogenized [OPG study]3.729639
GSM549120patient 078, normal, homogenized [OPG study]3.8526712
GSM549131patient 030, cancer, homogenized [OPG study]3.7771611
GSM549118patient 074, normal, homogenized [OPG study]3.8692112
GSM549129patient 027, cancer, homogenized [OPG study]3.608575
GSM549123patient 088, normal, homogenized [OPG study]3.769689
GSM549124patient 006, cancer, homogenized [OPG study]3.664666
GSM549126patient 015, cancer, homogenized [OPG study]3.669248
GSM549128patient 025, cancer, homogenized [OPG study]3.8170812
GSM549103patient 117, normal, homogenized [OPG study]3.750179
GSM549117patient 073, normal, homogenized [OPG study]3.695548
GSM549138patient 041, cancer, homogenized [OPG study]3.712799
GSM549141patient 045, cancer, homogenized [OPG study]3.690669
GSM549130patient 028, cancer, homogenized [OPG study]3.8699112
GSM549101patient 111, normal, homogenized [OPG study]3.7657210
GSM549105patient 128, normal, homogenized [OPG study]3.572865
GSM549106patient 134, normal, homogenized [OPG study]5.1081343
GSM549112patient 048, normal, homogenized [OPG study]3.67277
GSM549125patient 011, cancer, homogenized [OPG study]3.691888
GSM549127patient 024, cancer, homogenized [OPG study]4.1708321
GSM549135patient 035, cancer, homogenized [OPG study]3.439623